EP3546461
7-bensýl-4-(2-metýlbensýl)-2,4,6,7,8,9-hexahýdróimídasó[1,2-a]pýrídó[3,4-e]pýrímídín-5(1H)-ón, sölt þar af og aðferðir við að nota það í samsettri meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.9.2014EP published:
11.8.2021EP application number:
19158371.5
EP translation filed:
7.10.2021Grant published:
15.11.2021EPO information:
European Patent Register
Max expiry date:
11.9.2034Expiry date:
11.9.2026Next due date:
30.9.2026
Title:
7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY
Timeline
Today
12.9.2014EP application
11.8.2021EP Publication
7.10.2021Translation submitted
15.11.2021Registration published
11.9.2026Expires
Owner
Name:
Oncoceutics, Inc.Address:
3675 Market Street Suite 200, Philadelphia, PA 19104, US
Inventor
Name:
STOGNIEW, MartinAddress:
Blue Pell, PA 19422, US
Name:
ALLEN, Joshua E.Address:
New Haven, CT 06511, US
Name:
POTTORF, Richard S.Address:
Indianapolis, IN 46526, US
Name:
NALLAGANCHU, Bhaskara RaoAddress:
Hillsborough, NJ 08852, US
Name:
OLSON, Gary L.Address:
Mountainside, NJ 07092, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361904718 PDate:
15.11.2013Country:
US
Number:
201414208657Date:
13.3.2014Country:
US
Number:
201414341392Date:
25.7.2014Country:
US
Number:
PCT/US2014/048241Date:
25.7.2014Country:
WO
Classification
Categories:
C07D 471/14, A61K 31/519, A61K 31/44, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 13.9.2021
Expires: 11.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.8.2022
Expires: 11.9.2023
Payer: Patice ehf.
Number: 10
Paid: 28.8.2023
Expires: 11.9.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 22.8.2024
Expires: 11.9.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 10.9.2025
Expires: 11.9.2026
Payer: Árnason Faktor ehf.